Century Therapeutics, Inc. IPSC
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-17
Chart by TradingView
3/9
Piotroski F — financial health
-6.53
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $109.2M | $6.6M | $2.2M | $5.2M | — |
| Operating income | -$17.3M | -$138.1M | -$146.5M | -$133.8M | -$94.9M |
| Net income | -$9.6M | -$126.6M | -$136.7M | -$130.9M | -$95.8M |
| Operating cash flow | -$103.9M | -$110.1M | -$88.3M | $14.1M | -$89.0M |
| Free cash flow | -$104.7M | -$110.3M | -$102.1M | -$16.6M | -$134.0M |
| Total assets | $223.7M | $353.2M | $360.7M | $486.5M | $437.4M |
| Total liabilities | $64.8M | $191.9M | $175.9M | $183.8M | $41.1M |
| Shareholders' equity | $158.9M | $161.4M | $184.8M | $302.7M | $396.2M |
| Ratios | |||||
| Operating margin | -15.8% | -2096.5% | -6556.9% | -2574.2% | — |
| Net margin | -8.8% | -1920.9% | -6115.1% | -2518.4% | — |
| FCF margin | -95.9% | -1673.8% | -4567.5% | -318.4% | — |
| Return on assets | -4.3% | -35.8% | -37.9% | -26.9% | -21.9% |
| Return on equity | -6.0% | -78.4% | -74.0% | -43.2% | -24.2% |
| Debt / equity | — | — | — | 0.01× | 0.02× |
| Current ratio | 5.97 | 1.50 | 9.92 | 10.72 | 14.57 |
| Revenue growth | 1556.8% | 194.8% | -57.0% | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 5,964,678 | $13.5M |
| RENAISSANCE TECHNOLOGIES LLC | 906,827 | $2.0M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.53 (distress)
- Working capital / assets 0.449
- Retained earnings / assets -3.54
- EBIT / assets -0.077
- Equity / liabilities 2.454
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001850119 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.